연구성과로 돌아가기
2021 연구성과별 연구자 정보 (232 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation | Yu, Sungwook | Yu, S | 16 | Korea Univ, Anam Hosp, Dept Neurol, Coll Med, Seoul, South Korea | jhpark619@hanyang.ac.kr;mcastenosis@gmail.com; | |||||
| Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation | Park, Kwang Yeol | Park, KY | 17 | Chung Ang Univ, Dept Neurol, Coll Med, Seoul, South Korea | jhpark619@hanyang.ac.kr;mcastenosis@gmail.com; | |||||
| Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation | Kim, Jeong-Min | Kim, JM | 18 | Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea | ABH-2469-2021 | Kim, Jeong-Min | 0000-0001-7213-5527 | Kim, Jeong-Min | jhpark619@hanyang.ac.kr;mcastenosis@gmail.com; | |
| Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation | Choi, Jay Chol | Choi, JC | 19 | Jeju Natl Univ, Dept Neurol, Jeju City, South Korea | O-5940-2014 | choi, jo | jhpark619@hanyang.ac.kr;mcastenosis@gmail.com; | |||
| Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation | Seo, Woo-Keun | Seo, WK | 20 | 교신저자 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea | jhpark619@hanyang.ac.kr;mcastenosis@gmail.com; | ||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Quinn, D., I | Quinn, DI | 1 | 교신저자 | USC, Keck Sch Med, Div Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA | diquinn@med.usc.edu; | ||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Ng, C. F. | Ng, CF | 2 | Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China | E-5134-2011 | Ng, Chi-Fai | diquinn@med.usc.edu; | |||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Grande, E. | Grande, E | 3 | MD Anderson Canc Ctr, Dept Med Oncol, Madrid, Spain | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Kwon, T. G. | Kwon, TG | 4 | Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Linke, R. | Linke, R | 5 | SFJ Pharmaceut, Pleasanton, CA USA | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Lee, J-L | Lee, JL | 6 | Univ Ulsan, Asian Med Ctr, Dept Med Oncol, Coll Med, Seoul, South Korea | AGI-4843-2022 | Lee, Jae Lyun | diquinn@med.usc.edu; | |||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Rosbrook, B. | Rosbrook, B | 7 | Pfizer Oncol, New York, NY USA | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Thakur, M. N. | Thakur, MN | 8 | Pfizer, Sandwich, Kent, England | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Eto, M. | Eto, M | 9 | Kyushu Univ, Dept Urol, Fukuoka, Fukuoka, Japan | diquinn@med.usc.edu; | |||||
| ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups | Gross-Goupil, M. | Gross-Goupil, M | 10 | Ctr Hosp Univ Bordeaux, Dept Med Oncol, Bordeaux, France | diquinn@med.usc.edu; |
페이지 이동: